Sr. NGS Scientist, SOPHiA GENETICS
BIOGRAPHY
Redefining Precision Oncology with MSK-ACCESS® powered with SOPHiA DDM™
Presented at:
Precision Oncology Showcase
Speakers
-
Maria Fernanda Milanezi
Head of Molecular Pathology, Dasa Genomica Laboratory, Dasa BrazilBIOGRAPHY -
Ryan Demers, MSc
Global Diagnostics Director, Lung and Liquid Biopsy Strategy, AstraZenecaBIOGRAPHY
Abstract
Liquid biopsy has emerged as a revolutionary technology in the precision medicine field, by offering a non-invasive alternative to traditional tumor biopsies. While its potential for tumor detection and monitoring continues to grow, global adoption remains limited due to technical, workflow, and access-related barriers.
In a leading partnership with AstraZeneca, SOPHiA GENETICS is expanding access to liquid biopsy testing through the deployment of MSK-ACCESS® powered with SOPHiA DDM™, a best-in-class and decentralized NGS-based assay.
Join this insightful workshop to explore how a decentralized approach enables broader patient access to testing and accelerates pharmaceutical development, setting new standards in precision oncology.
In this session you will:
- Discover how the SOPHiA GENETICS decentralised approach and advanced analytics enables scalable, robust, and reproducible liquid biopsy testing, through its decentralized approach, supported by large-scale evidence generation studies across local deployments.
- Gain insights into the clinical impact and utility of adopting MSK-ACCESS® powered with SOPHiA DDM™, and how it improves access and outcomes for cancer patients.
- Explore how decentralized testing strategies support late-stage pharmaceutical development and drive commercial success in precision medicine.
You May Also Like
JAN 29, 2026 | 8:00 AM
Modern laboratories are under constant pressure to deliver results faster, more accurately, and with unwavering compliance. Organizations that harness next-generation LIMS capabilities gain...
FEB 18, 2026 | 8:00 AM
With advancing food allergy research and emerging therapies, new allergy testing requirements arise. In this context, Basophil Activation Testing (BAT) has emerged as an essential component...
FEB 18, 2026 | 1:00 PM
Energy-efficient filtration solutions that reduce hidden chemical exposure from benchtop work and lab equipment to improve overall laboratory safety...
FEB 19, 2026 | 8:00 AM
The collection of high-quality genomic DNA remains a major barrier in pediatric and neurodevelopmental research, particularly among children with autism spectrum disorder (ASD) and other neu...
FEB 23, 2026 | 9:00 AM
C.E. CREDITS
Explore decentralized liquid biopsy with SOPHiA GENETICS and MSK-ACCESS®, expanding access, improving outcomes, and accelerating precision oncology....
FEB 23, 2026 | 11:00 AM
The timing of the biological onset of multiple sclerosis (MS) is unclear. We used high-throughput discovery proteomics and samples from presymptomatic patients with MS and matched healthy co...
Loading Comments...